Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
07/02/2003 | EP1322332A2 Compositions and methods for inhibition of hiv-1 infection |
07/02/2003 | EP1322328A2 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
07/02/2003 | EP1322319A1 Use of il-8 protein modulators in the treatment of viral infections |
07/02/2003 | EP1043959A4 Interactive dental restorative network |
07/02/2003 | EP0900025B1 Moraxella catarrhalis outer membrane protein omp106, gene sequence and uses thereof |
07/02/2003 | EP0731845B1 Homologous recombination antibody expression system for murine cells |
07/02/2003 | CN1427892A Virulence genes, proteins and their use |
07/02/2003 | CN1427891A Anti-EGFRvIII scFv with improved cytotoxi city and yield, immunotoxins based thereon, and methods of use thereof |
07/01/2003 | US6586656 Transgenic rodents harboring APP allele having Swedish mutation |
07/01/2003 | US6586583 Recombinant DNA molecule comprising regulatory sequence in combination with a heterologous plant promoter and structural gene; use in pulp and paper bleaching, waste destruction, soil remediation, organic synthesis |
07/01/2003 | US6586578 Deformylase (def1); isolated polynucleotide of given sequence; detects Staphylococcus aureus; can use to screen for antibiotics |
07/01/2003 | US6586571 Isolated polypeptide that binds to MORT-1 (mediators of receptor toxicity) protein |
07/01/2003 | US6586569 Endometriosis-associated gene |
07/01/2003 | US6586568 Purified viral polypeptide comprising amino acid sequence encoded by positive stranded RNA genome which comprises an open reading frame encoding a polyprotein; use in diagnosing and providing safer blood and organ supply |
07/01/2003 | US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization |
07/01/2003 | US6586395 Apoptosis-modulating proteins |
07/01/2003 | US6586394 Tissue-derived tumor growth inhibitor |
07/01/2003 | US6586392 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
07/01/2003 | US6586242 TAO protein kinases and methods of use therefor |
07/01/2003 | US6586236 Modulation of polypeptide display on modified filamentous phage use |
07/01/2003 | US6586222 Recombinant PR-3 and compositions thereof |
07/01/2003 | US6586192 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
07/01/2003 | US6586191 Isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a |
07/01/2003 | US6586185 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
07/01/2003 | US6586182 Selecting amino acid sequence variations based on computer modeling; polynucleotides comprising subsequences of nucleic acids encoding the amino acid variations; reassembling into nucleotide sequences encoding mutagenized polypeptides |
07/01/2003 | US6586179 Human Eag2 |
07/01/2003 | US6585973 Solid phase adjuvant methodology is used to synthesize a hapten-protein-polysaccharide conjugate vaccines to stimulate an anti- polysaccharide antibody response in infants who are otherwise unable to respond to polysaccharide alone |
07/01/2003 | CA2123303C Icams immunoglobulin constant region soluble fusion proteins |
07/01/2003 | CA2122338C Novel human cdc25 genes, encoded products and uses therefor |
07/01/2003 | CA2080548C Monoclonal antibodies to hepatitis c virus |
07/01/2003 | CA2067469C Recombinant vaccine against marek's disease |
07/01/2003 | CA2046917C Polypeptides having thyrotropin-receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides |
06/26/2003 | WO2003052416A2 Focussed antibody technology |
06/26/2003 | WO2003052102A1 Specific antibody for detecting bradeion |
06/26/2003 | WO2003052082A2 Fusion partner cells and uses thereof |
06/26/2003 | WO2003052078A2 Insect g protein-coupled receptor genes and uses thereof |
06/26/2003 | WO2003052050A2 P450 enzymes, nucleic acids encoding them and methods of making and using them |
06/26/2003 | WO2003052048A2 Nucleic acid-associated proteins |
06/26/2003 | WO2003051928A1 Antibody specific for detection of bradeion |
06/26/2003 | WO2003051927A2 Production of f(ab')2 fragments in mammalian cells |
06/26/2003 | WO2003051926A2 Anti-cd7 immunotoxin as fusion protein |
06/26/2003 | WO2003051923A2 Novel g-protein coupled receptors and dna sequences thereof |
06/26/2003 | WO2003051910A2 Inhibitors of hepatitis c virus protease |
06/26/2003 | WO2003051720A2 A myeloma cell line useful for manufacturing recombinant proteins in chemically defined media |
06/26/2003 | WO2003051311A2 Antibody inhibiting stem cell factor activity and use for treatment of asthma |
06/26/2003 | WO2003051290A2 Treating b-cell mediated diseases by modulating dr6 activity |
06/26/2003 | WO2003035678A3 Sperm factor sequences |
06/26/2003 | WO2003024989A3 Activation and expansion of cells |
06/26/2003 | WO2003014153A8 Cellular virus receptors and methods of use. |
06/26/2003 | WO2003004636A3 Expression vectors encoding bacteriophage signal peptides |
06/26/2003 | WO2003000721A3 Mycobacterial antigens expressed under low oxygen tension |
06/26/2003 | WO2002102855A3 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
06/26/2003 | WO2002093128A3 Identifying insulin response modulators and therapeutic uses thereof |
06/26/2003 | WO2002070696A3 Cd109 nucleic acid molecules polypeptides and methods of use |
06/26/2003 | WO2002064766A3 Bax-responsive genes for drug target identification in yeast and fungi |
06/26/2003 | WO2002060953A3 Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer |
06/26/2003 | WO2002055738A3 Molecules for disease detection and treatment |
06/26/2003 | WO2002046385A3 Enzymes |
06/26/2003 | WO2002044406A3 Projection against mycobacterial infections |
06/26/2003 | WO2002016597A3 Lipid metabolism enzymes |
06/26/2003 | US20030121073 Use of acetoacetyl-CoA thiolase for identifying new fungicidally active substances |
06/26/2003 | US20030120059 Cell surface molecule-induced macrophage activation |
06/26/2003 | US20030120058 Polypeptides; proteolysis splitting; antitumor agents |
06/26/2003 | US20030120053 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/26/2003 | US20030120052 Human genetic engineering; cancer diagnosis; hybrid nucleic acid |
06/26/2003 | US20030120044 Methods of optimizing antibody variable region binding affinity |
06/26/2003 | US20030120043 Tumor necrosis factor receptor-associated factors |
06/26/2003 | US20030119715 Prevent retinoid binding; antiaging agents; activation cell differentiation |
06/26/2003 | US20030119185 Activation and expansion of cells |
06/26/2003 | US20030119168 Diagnosis of anticancer agents using nucleic acids |
06/26/2003 | US20030119146 Novel nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteins |
06/26/2003 | US20030119116 Fusion proteins; binding to antibodies |
06/26/2003 | US20030119111 G-protein coupled receptor, named 2871 receptor |
06/26/2003 | US20030119110 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/26/2003 | US20030119106 Fusion proteins; binding to antibodies |
06/26/2003 | US20030119103 Fusion proteins; binding to antibodies |
06/26/2003 | US20030119101 Bactericides, fungicides; transporter proteins |
06/26/2003 | US20030119097 Anticancer agents; screening genetic engineered libraries |
06/26/2003 | US20030119096 Detect, calibration binding of galanin; therapy for nervous system disorders |
06/26/2003 | US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides |
06/26/2003 | US20030119083 Generating antibodies; binding antigen; therapy for drug overdose |
06/26/2003 | US20030119082 Fluorescence immunoassay |
06/26/2003 | US20030119079 Using autoantibodies; vaccines |
06/26/2003 | US20030119078 Method of reducing immunogenicity of toxicity of an antibody of IgG class |
06/26/2003 | US20030119076 B7-like polynucleotides, polypeptides, and antibodies |
06/26/2003 | US20030119075 Anti-tissue factor antibodies with enhanced anticoagulant potency |
06/26/2003 | US20030119071 Tetrameric antibody complexes for blocking non-specific labeling of antigens |
06/26/2003 | US20030119070 Complexing ligand, peptide ; displacement of one ligand with another |
06/26/2003 | US20030119058 Method of assaying type III collagen degradation |
06/26/2003 | US20030119056 Focused libraries of genetic packages |
06/26/2003 | US20030119055 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/26/2003 | US20030119045 Controlling cell proliferation; adjust adhesion to substrate |
06/26/2003 | US20030119039 Detection using antibodies |
06/26/2003 | US20030119033 Immunoassay using antibodies |
06/26/2003 | US20030119018 Novel polynucleotides |
06/26/2003 | US20030119013 Identification of essential genes of Aspergillus fumigatus and methods of use |
06/26/2003 | US20030119001 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/26/2003 | US20030118990 Novel estrogen-regulated G protein gamma subunit: compositions and methods of use |
06/26/2003 | US20030118988 Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof |
06/26/2003 | US20030118985 Immunoassay using label; medical diagnosis |